Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-05-17 @ 4:09 PM
Study NCT ID:
NCT05563558
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2022-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
Sponsor:
Organization: